Multiple Sclerosis (MS)

Multiple Sclerosis (MS) is a chronic autoimmune disease that affects the central nervous system, including the brain, spinal cord, and optic nerves. In MS, the immune system mistakenly attacks the protective myelin sheath that covers nerve fibers, causing communication problems between the brain and the rest of the body.

What Happens in Multiple Sclerosis?

When myelin is damaged, nerve impulses slow down or become blocked. This process, called demyelination, leads to a wide range of symptoms that can vary greatly between individuals. Over time, the disease can cause permanent damage or deterioration of the nerve fibers themselves.

Types of Multiple Sclerosis

Relapsing-Remitting MS (RRMS)

The most common form, affecting about 85% of people with MS. RRMS is characterized by:

• Clear episodes of worsening symptoms (relapses)
• Periods of partial or complete recovery (remissions)
• No disease progression between relapses

Primary Progressive MS (PPMS)

Affects about 10-15% of people with MS. PPMS features:

• Gradual worsening of symptoms from the onset
• No distinct relapses or remissions
• Occasional plateaus or temporary minor improvements

Secondary Progressive MS (SPMS)

Many people with RRMS eventually transition to SPMS, which involves:

• Gradual worsening of symptoms
• Fewer or no relapses
• Progressive disability accumulation

Progressive-Relapsing MS (PRMS)

The rarest form, characterized by:

• Steady disease progression from onset
• Acute relapses with or without recovery
• Continued progression between relapses

Common Symptoms

MS symptoms vary widely depending on the amount of damage and which nerves are affected. Common symptoms include:

Neurological Symptoms

• Numbness or weakness in limbs
• Tingling or pain in parts of the body
• Electric-shock sensations with certain neck movements (Lhermitte sign)
• Tremor, lack of coordination, or unsteady gait

Vision Problems

• Partial or complete loss of vision, usually in one eye at a time
• Prolonged double vision
• Blurry vision
• Eye pain during movement

Cognitive & Emotional Changes

• Memory problems
• Difficulty concentrating
• Depression and anxiety
• Mood swings

Physical Symptoms

• Fatigue (one of the most common symptoms)
• Dizziness and vertigo
• Bladder and bowel dysfunction
• Sexual dysfunction
• Speech problems
• Difficulty swallowing

Causes & Risk Factors

The exact cause of MS remains unknown, but several factors may increase risk:

Immune System

MS is considered an autoimmune disorder where the immune system attacks the body's own tissues.

Genetics

Having a family member with MS increases your risk, though MS is not directly inherited.

Environmental Factors

• Geography: MS is more common in countries farther from the equator
• Vitamin D: Low vitamin D levels may increase risk
• Smoking: Significantly increases MS risk
• Infections: Certain viruses, particularly Epstein-Barr virus, are linked to MS

Demographics

• Age: Usually diagnosed between ages 20-40
• Sex: Women are 2-3 times more likely to develop RRMS
• Ethnicity: More common in people of Northern European descent

Diagnosis

There's no single test for MS. Diagnosis typically involves:

Medical History & Neurological Exam

Your doctor will review symptoms and perform tests of:

• Vision
• Coordination and balance
• Reflexes
• Sensation

MRI Scans

The most important diagnostic tool, revealing:

• Areas of demyelination (lesions) in the brain and spinal cord
• Active vs. old lesions
• Disease progression over time

Lumbar Puncture (Spinal Tap)

Analysis of cerebrospinal fluid can show:

• Abnormal antibodies associated with MS
• Elevated protein levels
• Ruling out other conditions

Evoked Potential Tests

Measure electrical signals sent by the brain in response to stimuli, detecting slowed signals caused by damaged myelin.

Blood Tests

Used primarily to rule out other conditions with similar symptoms.

Treatment Options

While there's no cure for MS, various treatments can help manage symptoms and slow disease progression.

Disease-Modifying Therapies (DMTs)

These medications can slow MS progression and reduce relapse frequency:

Injectable Medications

• Interferon beta medications (Avonex, Betaseron, Rebif)
• Glatiramer acetate (Copaxone)

Oral Medications

• Fingolimod (Gilenya)
• Dimethyl fumarate (Tecfidera)
• Teriflunomide (Aubagio)
• Siponimod (Mayzent)

Infusion Therapies

• Natalizumab (Tysabri)
• Ocrelizumab (Ocrevus)
• Alemtuzumab (Lemtrada)

Treatments for Relapses

• Corticosteroids (methylprednisolone or prednisone)
• Plasma exchange (plasmapheresis) for severe attacks

Symptom Management

• Physical therapy for mobility issues
• Muscle relaxants for spasticity
• Medications for fatigue, pain, bladder/bowel problems
• Antidepressants for mood disorders

Living with Multiple Sclerosis

Lifestyle Modifications

• Exercise: Regular physical activity improves strength, balance, and mood
• Diet: Balanced nutrition; some evidence supports vitamin D supplementation
• Stress Management: Stress may trigger relapses
• Adequate Rest: Fatigue management is crucial
• Avoid Heat: Heat can temporarily worsen symptoms

Emotional Support

• Join MS support groups
• Consider counseling or therapy
• Stay connected with family and friends
• Educate yourself about the condition

Work & Daily Life

• Discuss accommodations with employers
• Use assistive devices when needed
• Plan activities during peak energy times
• Prioritize important tasks

Prognosis

MS affects everyone differently. Many people with MS live full, productive lives. Factors affecting prognosis include:

• Type of MS
• Age at diagnosis
• Initial symptoms
• Response to treatment
• Frequency of relapses

With modern treatments, many people with MS maintain good quality of life and mobility for decades after diagnosis.

Experimental & Emerging Treatments

• Autologous Hematopoietic Stem Cell Transplant (AHSCT): High-dose chemo followed by stem cell rescue aims to “reset” the immune system. Small and mid-sized trials show durable remission for some people with aggressive RRMS, but the procedure carries serious risks and is limited to specialized centers.
• BTK Inhibitors: Oral drugs like evobrutinib and tolebrutinib target B-cell signaling. Phase III trials are underway to confirm whether they can match the efficacy of infused monoclonal antibodies with an easier dosing schedule.
• Remyelination Therapies: Agents such as opicinumab (anti-LINGO-1) and clemastine fumarate attempt to repair damaged myelin. Results are mixed, yet they remain a focus for combination regimens with rehab and neuroprotection strategies.
• Mesenchymal Stem Cell (MSC) Infusions: Intravenous or intrathecal MSCs are being studied for their ability to calm inflammation and support repair. Early findings are promising for certain biomarkers, but protocols remain investigational.

When to Track Your Symptoms

If you have MS, consistent symptom tracking is essential for:

• Identifying patterns and triggers
• Monitoring treatment effectiveness
• Early detection of relapses
• Better communication with healthcare providers

Track your MS symptoms with Diagnoza.care - Our intelligent symptom tracker helps you monitor changes, identify patterns, and share comprehensive reports with your medical team.

---

Medical Disclaimer: This information is for educational purposes only and should not replace professional medical advice. Always consult with qualified healthcare providers for diagnosis and treatment. Sources: National Multiple Sclerosis Society, Mayo Clinic, National Institute of Neurological Disorders and Stroke